Connection
Marc Bonaca to Tissue Plasminogen Activator
This is a "connection" page, showing publications Marc Bonaca has written about Tissue Plasminogen Activator.
|
|
Connection Strength |
|
 |
|
 |
|
0.177 |
|
|
|
-
Bonaca MP, Szarek M, Debus ES, Nehler MR, Patel MR, Anand SS, Muehlhofer E, Berkowitz SD, Haskell LP, Bauersachs RM. Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a "CASPAR like" outcome from VOYAGER PAD. Clin Cardiol. 2022 Dec; 45(12):1143-1146.
Score: 0.177